190 related articles for article (PubMed ID: 23383610)
1. Identification of ovarian cancer associated genes using an integrated approach in a Boolean framework.
Kumar G; Breen EJ; Ranganathan S
BMC Syst Biol; 2013 Feb; 7():12. PubMed ID: 23383610
[TBL] [Abstract][Full Text] [Related]
2. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
3. Network-based inference framework for identifying cancer genes from gene expression data.
Yang B; Zhang J; Yin Y; Zhang Y
Biomed Res Int; 2013; 2013():401649. PubMed ID: 24073403
[TBL] [Abstract][Full Text] [Related]
4. Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.
Emmanuel C; Gava N; Kennedy C; Balleine RL; Sharma R; Wain G; Brand A; Hogg R; Etemadmoghadam D; George J; ; Birrer MJ; Clarke CL; Chenevix-Trench G; Bowtell DD; Harnett PR; deFazio A
PLoS One; 2011 Mar; 6(3):e17617. PubMed ID: 21423607
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive understanding of ovarian carcinoma survival prognosis by novel biomarkers.
Wang Y; Lei L; Chi YG; Liu LB; Yang BP
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8257-8264. PubMed ID: 31646556
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
7. Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies.
Ben-Hamo R; Efroni S
BMC Syst Biol; 2012 Jan; 6():3. PubMed ID: 22236809
[TBL] [Abstract][Full Text] [Related]
8. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
[TBL] [Abstract][Full Text] [Related]
9. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
10. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
[TBL] [Abstract][Full Text] [Related]
11. A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer.
Nagaraj SH; Reverter A
BMC Syst Biol; 2011 Feb; 5():35. PubMed ID: 21352556
[TBL] [Abstract][Full Text] [Related]
12. Prediction of key genes in ovarian cancer treated with decitabine based on network strategy.
Wang YZ; Qiu SC
Oncol Rep; 2016 Jun; 35(6):3548-58. PubMed ID: 27035425
[TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.
Colaprico A; Cava C; Bertoli G; Bontempi G; Castiglioni I
Biomed Res Int; 2015; 2015():831314. PubMed ID: 26240829
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
15. Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.
Sinha S; Singh RK; Bhattacharya N; Mukherjee N; Ghosh S; Alam N; Roy A; Roychoudhury S; Panda CK
Mol Oncol; 2011 Oct; 5(5):454-64. PubMed ID: 21803008
[TBL] [Abstract][Full Text] [Related]
16. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer.
Zhao L; Li Y; Zhang Z; Zou J; Li J; Wei R; Guo Q; Zhu X; Chu C; Fu X; Yue J; Li X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33135729
[TBL] [Abstract][Full Text] [Related]
18. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
Mercier PL; Bachvarova M; Plante M; Gregoire J; Renaud MC; Ghani K; Têtu B; Bairati I; Bachvarov D
Mol Oncol; 2011 Oct; 5(5):438-53. PubMed ID: 21856257
[TBL] [Abstract][Full Text] [Related]
19. Novel gene signatures for prognosis prediction in ovarian cancer.
Bao M; Zhang L; Hu Y
J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
[TBL] [Abstract][Full Text] [Related]
20. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
